Lifecore Biomedical: Bid Is Underwhelming
Lifecore Biomedical Inc LFCR
$6.59
โฒ +1.07%
(+$0.07)
Open
$6.53
Prev Close
$6.52
Day Range
$6.51 โ $6.61
52W Range
$3.63 โ $8.98
Market Cap
$249.45M
Beta
1.04
EPS (TTM)
$-1.31
๐ Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1996-02-15 |
| Shares Out. | 37,510,000 |
| Website | lifecore.com/ โ |
| Phone | 18009279800 |
| Employees | 382 |
| Revenue | $34.2M |
| Gross Profit | $12.1M |
| Net Income | -$6.2M |
| Total Assets | $229.5M |
| Total Liabilities | $213.4M |
| Equity | -$34.1M |
About Lifecore Biomedical Inc
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
Lifecore Biomedical Inc is a publicly traded company under the ticker symbol LFCR on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
11 analysts (2026-09-01)
๐ฐ Latest News for LFCR
Top stock movements in today's session.
Let's take a look at the stocks that are in motion in today's session.
Let's uncover which stocks are experiencing notable gaps during today's session.
William Blair Downgrades Lifecore Biomedical to Market Perform
12 Health Care Stocks Moving In Monday's Intraday Session
Lifecore Biomedical to be Acquired by Webster Equity Partners
Lifecore Biomedical To Be Acquired By Webster Equity Partners In Up To $663.7M Transaction; Stockholders May Receive Up To $9.67 Per Common Equivalent In Combined Cash And CVR At Full Performance Milestone Payments

